Unimed Pharmaceutical (002581.SZ) subsidiary plans to acquire a 51% equity stake in Gukang Pharmaceutical, a traditional Chinese medicine and Chinese herbal medicine enterprise.

Smart Financial News APP message, Unimed Pharmaceutical (002581.SZ) announced that its wholly-owned subsidiary Beida Unimed (Shanghai) Biopharmaceutical Co., Ltd. (referred to as "Shanghai Unimed") plans to increase its capital by 45 million yuan to Sichuan Gukang Pharmaceutical Co., Ltd. (referred to as "Gukang Pharmaceutical") and acquire 51% of Gukang Pharmaceutical's equity.